Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 08 - 12 tags : Disease save search
Rhythm Pharmaceuticals to Present at the 59th Annual ESPE MeetingCompany announces acceptance of seven abstracts with data from multiple clinical trials evaluating setmelanotide for rare genetic diseases of obesity
Published: 2021-08-12 (Crawled : 12:15) - biospace.com/
RYTM 4 | $39.71 -0.73% -0.73% 400K
|
Health Technology
|
| O: 0.0%
H: 3.41%
C: 3.12%
disease obesity genetic clinical trials trial setmelanotide rare
VTX-801 Receives U.S. FDA Fast Track Designation for the Treatment of Wilson Disease
Published: 2021-08-12 (Crawled : 12:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.41%
H: 1.94%
C: 1.59%
disease treatment fda fda fast track fast track fast track designation designation
VYNE Therapeutics Reports Second Quarter 2021 Financial Results and Announces New Strategic Direction to Develop Treatments for Immunological and Inflammatory Diseases
Published: 2021-08-12 (Crawled : 12:00) - globenewswire.com
VYNE | $2.65 14.22% 12.45% 380K
|
Health Technology
|
| O: -18.69%
H: 3.83%
C: -15.32%
disease treatment financial results results
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.